Index A – histology of maternal response 1023, 1024 – of the skin 87 AAM see aggressive angiomyxoma (AAM) – maternal response 1023 – of the urethra 96 abdominal endometriosis 661 – neonatal infection 1027 – to the vulva, metastatic 89 abdominal pain 540 – pathogenesis 1022 – of primary peritoneal origin 638 abdominal scar–related endometriosis 659 – preterm birth (PTB) 1026 – of the vulva, primary 81 ablation, effects on endometrium 351 acute fatty liver of pregnancy (AFLP) 1063 – signet–ring cell 629 abnormal mitotic figure (AMF) 214, 219 acute on chronic transfusion, TTTS 1017 – well–differentiated 367 – in SIL 215 acute twin–twin transfusion syndrome – with diffuse peritoneal involvement 638 abortion 1064 (TTTS) 1016 adenocarcinoma in situ (AIS) 219, 278 abscess, tubo–ovarian 544 acute villitis, histology 1025 – of the cervix 227 absent ovary 581 acyclovir 10 – of the cervix, clinical features 227 ACA see acute chorioamnionitis (ACA) 1022 Addison’s disease, and autoimmune – of the cervix, differential diagnosis 229 acantholysis 30, 31 oophoritis 613 – of the cervix, TBS terminology 239 acantholytic disease of the vulva, localized 29 adenoacanthoma (AA) 413 – clinical behavior 232 acantholytic squamous cell carcinoma of the adenocarcinoma 83, 657 – colonic type 228 vulva 78 – arising in mesonephric duct remnants 147 – distribution in the cervix 228 – histology 78 – endocervical type 240 – endocervical glands 228 acanthosis 23, 39, 134, 137, 210 – endometrial type 240 – endocervical type 228 acanthosis nigricans (AN) 597, 840 – high–grade, histology 427 – histological types 228 – and HAIR–AN syndrome 603 – in the endometrium, well–differentiated 376 – histology 228, 240 – of the vulva 35 – involving peritoneum, histology 641 – intestinal type, histology 229 acardiac fetus 1020 – of cloacogenic origin 86 – mitotic figures and apoptotic bodies 229 acardiac twin, multiple pregnancy 1019 – of the cervix 84, 254, 273 – p16ink staining, histology 231 Acarina 27 – of the cervix, clinical features 274 – pathologic findings 228 accelerated maturation, maternal circulatory – of the cervix, endometrioid type 284 – treatment 232 disorders 1035 – of the cervix, endometrioid type, adenofibroma 295, 505 accessory lobe 1003 histology 284 – andmetastaticcarcinoidtumorinovary958 accessory ovary 581 – of the cervix, mucinous type 280 – histology 501–553 acne, and PCOS 597 – of the cervix, mucinous type, – of the endometrium 348 acquired immunodeficiency virus syndrome histology 280 – of the endometrium, diagnosis 348 (AIDS) 118 – of the cervix, pathogenesis 273 – of the endometrium, differential acrochordon 38 – of the cervix, prevalence 273 diagnosis 349 actin 461 – of the cervix, risk factors 273 – of the endometrium, histology 349 actinomyces, endometritis 326 – of the cervix, TBS terminology 240 – of the fallopian tube 553 Actinomyces israelii 544 – of the cervix, usual type 276 – of the uterus 500, 501 – infection of the cervix 174 – of the cervix, usual type, clinical – of the uterus, clinical behavior 502 Actinomycetes 118, 626 behavior 279 – of the uterus, clinical features 501 – Papanicolaou–stained cytologic – of the cervix, usual type, differential – of the uterus, differential diagnosis 501 preparation 118 diagnosis 278 – of the uterus, gross findings 501 actinomycosis 583 – of the cervix, usual type, gross – of the uterus, microscopic findings 501 – of the cervix 174 findings 276 – of the uterus, treatment 502 – of the ovary 583 – of the cervix, usual type, – ovarian cancer 703 – of the ovary, histology 584 immunohistochemical findings 277 adenoid basal carcinoma actinomycotic granule (AMG) 326 – of the cervix, usual type, major prognostic – histology 289 active chronic villitis 1028 indicators 279 – of the cervix 289 acute atherosis – of the cervix, usual type, microscopic adenoid basal cell carcinoma 147 – histology 1035 findings 276 – of the vulva 81 – maternal circulatory disorders 1034 – of the cervix, usual type, risk factors 279 adenoid basal epithelioma 290 acute chorioamnionitis (ACA) 1022 – of the cervix, usual type, treatment 279 – associated with invasive squamous cell – clinical significance 1026 – of the cervix, villoglandular type 282 carcinoma, histology 290 – etiology 1022 – of the cervix, villoglandular type, – histology 290 – fetal inflammatory response 1024 histology 283 adenoid cystic carcinoma 147, 289 – frequency 1022 – of the endometrium 146 – histology 88, 288 – histology of fetal response 1024, 1025 – of the mammary–like tissue of the vulva 44 – of the Bartholin gland 87 1206 Index – of the Bartholin gland, differential adipose prosoplasia 920 AIDS see acquired immunodeficiency virus diagnosis 87 adipose tissue, tumor of 44 syndrome (AIDS) – of the cervix 288 adnexal torsion 615 AIM see atypical immature metaplasia (AIM) adenoid squamous carcinoma of the vulva 78 adrenal androgen, and PCOS 599 AIS see adenocarcinoma in situ (AIS) adenoma of minor vestibular gland 42 adrenal cortical carcinoma, ovarian albinism 32 adenomatoid tumor 132, 635 involvement 974 allantoic remnant – and yolk sac tumor 920 adrenal cortical rest 581 – histology 1050 – histology 551, 920 – histology 582 – umbilical cord 1050 – hypertrophic myometrium, histology 514 – in the ovary 581 allergic reaction to seminal fluid 121 – of the fallopian tube 550 – within mesovarium, histology 582 alpha–fetoprotein (AFP) 425 – of the ovary 920 adrenal gland tumor, ovarian involvement 973 – dysgerminoma 853 – of the uterus 514 adrenal hyperplasia, and PCOS 600 – hepatoid carcinoma of the ovary 923 – of the uterus, clinical features 514 adrenal rest, histology 569 – yolk sac tumor 856, 857, 861, 863 – of the uterus, pathologic findings 514 adrenal tumor, and PCOS 600 alpha–fetoprotein (AFP)–secreting hepatoid adenomatous dermal tumor 40 adrenocortical carcinoma, and steroid cell adenocarcinoma of the endometrium 440 adenomatous hyperplasia of the tumor not otherwise specified (NOS) 831 alpha–smooth muscle actin 461 endometrium 360 adrenocortical nodule of the placenta 1066 ALTS see ASCUS–LSIL Traige Study (ALTS) adenomyoma adriamycin, treatment of serous carcinoma 423 alveolar rhabdomyosarcom 507 – histology 346 adult granulosa cell tumor (AGCT) 788 alveolar soft part sarcoma (ASPS) 147, 294 – of the cervix 185, 295 – and Call–Exner body 796 – behavior 1188 – of the fallopian tube 553 – and cellular thecomas 794 – clinical features 1187 – of the uterus 512 – and crystal of Reinke 792 – differential diagnosis 1187 – of the uterus, clinical features 512 – and endometrioid carcinoma 795 – histology 510, 1188 – of the uterus, pathologic findings 512 – and fibromas 794 – involving gynecologic tract 1186 adenomyomatous polyp 346 – and fibrosarcomas 794 – of the uterus 510 – histology 346 – and stromal tumors 794 – of the uterus, differential diagnosis 510 adenomyosis 405 – and theca cell 793 – pathologic findings 1187 – histology 512 – and undifferentiated carcinoma 793 – treatment 1188 – intravascular endometrial tissue, – androgenic changes 789 amebiasis 548 histology 513 – clinical behavior 797 amenorrhea 540, 597 – of the uterus 512 – clinical features 788 American Joint Commission on Cancer – of the uterus, clinical features 512 – differential diagnosis 793 (AJCC) staging system 73 – of the uterus, pathologic findings 512 – endometrial changes 789 AMF – sparse glands, histology 514 – gross findings 789 – see abnormal mitotic figure (AMF) adenosarcoma 345, 349, 496, 502, 509, 654, 772 – histology 789–799 – see angiomyofibroblastoma (AMF) – histology 503, 504 – microscopic findings 790 amnion adhesion malformation syndrome 1047 – of the uterus 500, 502 – nuclear features 791 amnion nodosum – of the uterus, clinical behavior 506 – patterns 790 – clinical features 1046 – of the uterus, clinical features 503 – size 798 – definition 1046 – of the uterus, differential diagnosis 505 – stages 798 – diseases of the placenta 1046 – of the uterus, gross findings 503 – treatment 797 – etiology 1046 – of the uterus, immunohistochemistry 505 – versus Sertoli–Leydig cell tumor 823 – histology 1046 – of the uterus, microscopic findings 503 adventitia 108 – pathology 1046 – of the uterus, staging 456 AFP see alpha–fetoprotein (AFP) amnionic band – of the uterus, treatment 506 AGC see atypical glandular cells (AGC) – clinical significance 1048 – periglandular stromal hypercellularity, AGCT see adult granulosa cell tumor (AGCT) – definition 1046 histology 504 agenesis of the lower vagina 106 – diseases of the placenta 1046 – rhabdomyosarcoma in zones of aggressive angiomyxoma (AAM) – disruption complex 1047 sarcomatous overgrowth, histology 505 – age distribution of patients 1160 – etiology 1048 – sarcomatous overgrowth, histology 505 – behavior 1163 – pathology 1047 – sex cord–like trabeculae, histology 504 – clinical features 1160 amnionic band syndrome 1047 – stromal cells, histology 504 – differential diagnosis 1161 amnionic infection, diseases of placenta 1025 adenosis 111, 139 – histology 1161, 1162 amnionicity, multiple pregnancy 1008 – histology 113 – immunohistochemistry 1163 amoebas 626 adenosquamous carcinoma (AS) 78, 146, 413 – pathologic findings 1160 ampulla of the fallopian tube 533 – histology 287 – treatment 1163 – histology 534 – of the Bartholin gland 87 aggressive endometriosis 772 amputation of cervix 261 – of the cervix 286 AGUS see atypical glandular cells of amyloidosis – vulvar, treatment 89 undetermined significance (AGUS) – of the ovary 617 adipose metaplasia in endometrium 342 AH see atypical hyperplasia (AH) – of the vulva 45 Index 1207 AN see acanthosis nigricans